Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Diamond, Eli L., Subbiah, Vivek ORCID: 0000-0002-6064-6837, Lockhart, A. Craig, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Puzanov, Igor, Chau, Ian, Raje, Noopur S., Wolf, Jurgen, Erinjeri, Joseph P., Torrisi, Jean, Lacouture, Mario, Elez, Elena ORCID: 0000-0002-4653-6324, Martinez-Valle, Ferran, Durham, Benjamin ORCID: 0000-0001-8090-5448, Arcila, Maria E., Ulaner, Gary, Abdel-Wahab, Omar, Pitcher, Bethany, Makrutzki, Martina, Riehl, Todd, Baselga, Jose and Hyman, David M. (2018). Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study. JAMA Oncol., 4 (3). S. 384 - 389. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445

Hyman, David M., Tran, Ben, Paz-Ares, Luis, Machiels, Jean-Pascal, Schellens, Jan H., Bedard, Philippe L., Campone, Mario, Cassier, Philippe A., Sarantopoulos, John, Vaishampayan, Ulka, Chugh, Rashmi, Mahipal, Amit, Lockhart, A. Craig, Sessa, Cristiana, Zander, Thomas, Ng, Matthew, Curigliano, Giuseppe ORCID: 0000-0003-1781-2518, Bendiske, Jennifer, Chen, Xueying, Choudhury, Somesh, Graus-Porta, Diana, Lewis, Nancy, Perez Garcia, Jose Manuel and Jose de Miguel-Luken, Maria (2019). Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations. JCO Precis. Oncol., 3. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 2473-4284

Hyman, David Michael, Kaley, Thomas Joseph, Hollebecque, Antoine ORCID: 0000-0003-2869-7551, Subbiah, Vivek ORCID: 0000-0002-6064-6837, Ahnert, Jordi Rodon, Lockhart, A. Craig, Keedy, Vicki Leigh, Hofheinz, Railf, Lobbedez, Florence Joly, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Chau, Ian, Puzanov, Igor, Raje, Noopur, Wolf, Juergen, Makrutzki, Martina, Riehl, Todd, Pitcher, Bethany and Baselga, Jose (2017). Vemurafenib in patients with BRAF(V600) mutant glioma: A cohort of the histology-independent VE-basket study. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kaley, Thomas, Touat, Mehdi, Subbiah, Vivek ORCID: 0000-0002-6064-6837, Hollebecque, Antoine, Rodon, Jordi, Lockhart, A. Craig, Keedy, Vicki, Bielle, Franck, Hofheinz, Ralf-Dieter, Joly, Florence, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Chau, Ian, Puzanov, Igor, Raje, Noopur S., Wolf, Jurgen, DeAngelis, Lisa M., Makrutzki, Martina, Riehl, Todd, Pitcher, Bethany, Baselga, Jose and Hyman, David M. (2018). BRAF Inhibition in BRAF(V600)-Mutant Gliomas: Results From the VE-BASKET Study. J. Clin. Oncol., 36 (35). S. 3477 - 3487. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Subbiah, Vivek ORCID: 0000-0002-6064-6837, Puzanov, Igor, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Chau, Ian ORCID: 0000-0003-0286-8703, Lockhart, A. Craig, Raje, Noopur S., Wolf, Juergen, Baselga, Jose, Meric-Bernstam, Funda, Roszik, Jason ORCID: 0000-0002-4561-6170, Diamond, Eli L., Riely, Gregory J., Sherman, Eric J., Riehl, Todd, Pitcher, Bethany and Hyman, David M. (2020). Pan-Cancer Efficacy of Vemurafenib in BRAF(V)(600)-Mutant Non-Melanoma Cancers. Cancer Discov., 10 (5). S. 657 - 664. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 2159-8290

This list was generated on Wed Mar 3 04:32:19 2021 CET.